Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

被引：38
|
作者：
Hongeng, S
Tardtong, P
Worapongpaiboon, S
Ungkanont, A
Jootar, S
机构：
[1] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok 10400, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Dept Pathol, Bangkok 10400, Thailand
[3] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Internal Med, Bangkok 10400, Thailand
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷 / 10期
关键词：
unrelated bone marrow transplantation; autoimmune haemolytic anaemia; rituximab;
D O I：
10.1038/sj.bmt.1703551
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Here, we report a case of paediatric beta-thalassaemia major patient who underwent unrelated T cell-non-depleted bone marrow transplantation and developed a complication of autoimmune haemolytic anaemia (AIHA) refractory to corticosteroid and intravenous immunoglobulin therapy. After this child received two doses (375 mg/m(2)/dose) of rituximab (anti-CD20 monoclonal antibody), his AIHA was resolved.
引用
收藏
页码：871 / 872
页数：2
相关论文
共 50 条
  • [21] Successful treatment of warm-type haemolytic anaemia with bortezomib in a rituximab-failed systemic lupus erythematosus patient
    Wang, Yu
    Zhou, Wei
    Zhang, Zhuoli
    RHEUMATOLOGY, 2015, 54 (01) : 194 - 195
  • [22] SUCCESSFUL USE OF MTOR INHIBITOR FOR STABILIZATION OF FALLING CHIMERISM POST UNRELATED BONE MARROW TRANSPLANT IN A PATIENT WITH A HISTORY OF SICKLE CELL DISEASE AND STROKE
    Lyons, Kelly
    Ahmed-Winston, Sameeya
    Nickel, Robert
    Webb, Jennifer
    Abraham, Allistair
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S231 - S231
  • [23] Efficacy of low dose intravenous immunoglobulins for post-splenectomy treatment of autoimmune haemolytic anaemia in a patient with hereditary spherocytosis
    Ames, PRJ
    Nardiello, S
    Tommasino, C
    CLINICAL AND LABORATORY HAEMATOLOGY, 2000, 22 (04): : 225 - 228
  • [24] THE PLATELET-REFRACTORY BONE-MARROW TRANSPLANT PATIENT - PROPHYLAXIS AND TREATMENT OF BLEEDING
    BENSON, K
    FIELDS, K
    HIEMENZ, J
    ZORSKY, P
    BALLESTER, O
    PERKINS, J
    ELFENBEIN, G
    SEMINARS IN ONCOLOGY, 1993, 20 (05) : 102 - 109
  • [25] Rituximab and immune modulation post unrelated donor transplant as treatment for refractory Burkitt's-like lymphoma.
    McGuirk, JP
    Dix, SP
    Belt, RJ
    BLOOD, 2000, 96 (11) : 242B - 242B
  • [26] Autoimmune haemolytic anaemia associated with epstein barr virus infection as a severe late complication after kidney transplantation and successful treatment with rituximab: case report
    Hamilton, Alexander J.
    Webb, Lynsey H.
    Williams, Jennifer K.
    D'Souza, Richard J.
    Ngu, Loretta S. P.
    Moore, Jason
    BMC NEPHROLOGY, 2015, 16
  • [27] Autoimmune haemolytic anaemia associated with epstein barr virus infection as a severe late complication after kidney transplantation and successful treatment with rituximab: case report
    Alexander J Hamilton
    Lynsey H Webb
    Jennifer K Williams
    Richard J D’Souza
    Loretta SP Ngu
    Jason Moore
    BMC Nephrology, 16
  • [28] Successful treatment with rituximab of pure red cell aplasia in allogeneic bone marrow transplant with major ABO mismatch
    Bazarbachi, A
    El Sayyad, M
    Baz, EMK
    BONE MARROW TRANSPLANTATION, 2006, 37 : S69 - S69
  • [29] Rituximab for the treatment of post-bone marrow transplantation refractory hemolytic anemia in a child with Omenn's syndrome
    Silvana, Briuglia
    Antonella, La Mazza
    Basilia, Piraino
    Trombetta, Domenico
    Saija, Antonella
    Salpietro, Carmelo
    PEDIATRIC TRANSPLANTATION, 2007, 11 (05) : 552 - 556
  • [30] Red Cell Alloimmunization followed by Refractory Autoimmune Hemolytic Anemia Post-Bone Marrow Transplant in an Infant with SCID
    Paraiso, C.
    Perumbeti, A.
    TRANSFUSION, 2016, 56 : 143A - 143A
12345